| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Wound Infection | 23 | 2017 | 108 | 4.380 |
Why?
|
| Medicare | 45 | 2014 | 126 | 3.140 |
Why?
|
| Pneumonia | 23 | 2015 | 89 | 3.010 |
Why?
|
| Quality Assurance, Health Care | 16 | 2014 | 64 | 2.410 |
Why?
|
| Anti-Bacterial Agents | 17 | 2017 | 537 | 1.960 |
Why?
|
| United States | 74 | 2022 | 2247 | 1.750 |
Why?
|
| Antibiotic Prophylaxis | 10 | 2017 | 38 | 1.730 |
Why?
|
| Hospitals | 16 | 2014 | 77 | 1.690 |
Why?
|
| Hospitalization | 17 | 2024 | 201 | 1.610 |
Why?
|
| Pneumococcal Vaccines | 8 | 2015 | 20 | 1.570 |
Why?
|
| Quality Indicators, Health Care | 13 | 2015 | 54 | 1.350 |
Why?
|
| Pneumococcal Infections | 7 | 2015 | 24 | 1.340 |
Why?
|
| Quality of Health Care | 13 | 2014 | 84 | 1.270 |
Why?
|
| Surgical Procedures, Operative | 10 | 2013 | 49 | 1.130 |
Why?
|
| Influenza, Human | 10 | 2005 | 95 | 1.120 |
Why?
|
| Influenza Vaccines | 7 | 2006 | 55 | 1.080 |
Why?
|
| Humans | 107 | 2025 | 28998 | 1.070 |
Why?
|
| Vaccination | 9 | 2015 | 213 | 1.070 |
Why?
|
| Guideline Adherence | 11 | 2015 | 97 | 1.000 |
Why?
|
| Venous Thromboembolism | 5 | 2022 | 137 | 0.990 |
Why?
|
| Pneumonia, Bacterial | 6 | 2008 | 18 | 0.930 |
Why?
|
| Hospital Mortality | 10 | 2012 | 159 | 0.930 |
Why?
|
| Global Health | 1 | 2025 | 55 | 0.920 |
Why?
|
| Aged | 52 | 2021 | 5608 | 0.890 |
Why?
|
| Public Health | 1 | 2025 | 97 | 0.870 |
Why?
|
| Community-Acquired Infections | 11 | 2008 | 31 | 0.820 |
Why?
|
| Practice Patterns, Physicians' | 8 | 2013 | 177 | 0.790 |
Why?
|
| Aged, 80 and over | 31 | 2021 | 2067 | 0.750 |
Why?
|
| Myocardial Infarction | 10 | 2015 | 351 | 0.740 |
Why?
|
| Financial Management | 1 | 2022 | 6 | 0.740 |
Why?
|
| Reimbursement, Incentive | 4 | 2013 | 6 | 0.700 |
Why?
|
| Retrospective Studies | 29 | 2017 | 2644 | 0.680 |
Why?
|
| Arthroplasty, Replacement, Hip | 5 | 2014 | 29 | 0.640 |
Why?
|
| General Surgery | 2 | 2013 | 63 | 0.600 |
Why?
|
| Anticoagulants | 5 | 2017 | 297 | 0.580 |
Why?
|
| Male | 47 | 2024 | 13983 | 0.570 |
Why?
|
| Female | 48 | 2024 | 15690 | 0.550 |
Why?
|
| Oklahoma | 18 | 2024 | 1058 | 0.550 |
Why?
|
| Infection Control | 4 | 2013 | 33 | 0.540 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2014 | 38 | 0.540 |
Why?
|
| Immunization Programs | 4 | 2005 | 20 | 0.530 |
Why?
|
| Clostridium Infections | 1 | 2017 | 67 | 0.500 |
Why?
|
| Population Surveillance | 8 | 2015 | 87 | 0.480 |
Why?
|
| Time Factors | 15 | 2021 | 1619 | 0.470 |
Why?
|
| Risk Factors | 15 | 2022 | 2134 | 0.450 |
Why?
|
| Anti-Infective Agents | 2 | 2013 | 78 | 0.430 |
Why?
|
| Practice Guidelines as Topic | 7 | 2012 | 249 | 0.430 |
Why?
|
| Disease Notification | 1 | 2013 | 1 | 0.410 |
Why?
|
| Epidemiological Monitoring | 1 | 2013 | 6 | 0.410 |
Why?
|
| Peer Review, Health Care | 1 | 2013 | 3 | 0.410 |
Why?
|
| Hospitals, Low-Volume | 1 | 2013 | 3 | 0.400 |
Why?
|
| Hospitals, High-Volume | 1 | 2013 | 8 | 0.400 |
Why?
|
| Value-Based Purchasing | 1 | 2012 | 3 | 0.390 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 4 | 0.390 |
Why?
|
| Fluoroquinolones | 3 | 2008 | 15 | 0.390 |
Why?
|
| Coronary Artery Bypass | 4 | 2014 | 68 | 0.380 |
Why?
|
| Perioperative Care | 1 | 2012 | 35 | 0.380 |
Why?
|
| Physicians | 2 | 2019 | 83 | 0.370 |
Why?
|
| Patient Discharge | 2 | 2012 | 109 | 0.370 |
Why?
|
| Treatment Outcome | 12 | 2013 | 2427 | 0.370 |
Why?
|
| Nursing Homes | 4 | 2008 | 51 | 0.360 |
Why?
|
| Heparin | 2 | 2012 | 111 | 0.360 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2010 | 3 | 0.330 |
Why?
|
| Drug Hypersensitivity | 3 | 2005 | 23 | 0.330 |
Why?
|
| Medical Informatics Applications | 1 | 2010 | 7 | 0.330 |
Why?
|
| Macrolides | 2 | 2008 | 19 | 0.330 |
Why?
|
| Total Quality Management | 3 | 2005 | 11 | 0.320 |
Why?
|
| Inpatients | 3 | 2010 | 60 | 0.320 |
Why?
|
| Models, Statistical | 1 | 2011 | 128 | 0.320 |
Why?
|
| Electronic Health Records | 1 | 2010 | 67 | 0.310 |
Why?
|
| Internship and Residency | 1 | 2013 | 263 | 0.310 |
Why?
|
| Cohort Studies | 10 | 2014 | 898 | 0.300 |
Why?
|
| Long-Term Care | 3 | 2005 | 32 | 0.290 |
Why?
|
| Stroke | 2 | 2012 | 261 | 0.290 |
Why?
|
| Cross Infection | 3 | 2014 | 37 | 0.290 |
Why?
|
| Middle Aged | 17 | 2021 | 7428 | 0.280 |
Why?
|
| Bacterial Infections | 1 | 2008 | 56 | 0.280 |
Why?
|
| Patient Readmission | 6 | 2012 | 108 | 0.280 |
Why?
|
| Incidence | 9 | 2022 | 573 | 0.280 |
Why?
|
| Postoperative Complications | 1 | 2012 | 635 | 0.270 |
Why?
|
| Healthcare Disparities | 3 | 2014 | 97 | 0.260 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 7 | 0.260 |
Why?
|
| Atypical Bacterial Forms | 1 | 2007 | 2 | 0.260 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2011 | 52 | 0.250 |
Why?
|
| Health Care Surveys | 6 | 2011 | 69 | 0.250 |
Why?
|
| Pulmonary Embolism | 2 | 2022 | 126 | 0.250 |
Why?
|
| Length of Stay | 6 | 2006 | 246 | 0.250 |
Why?
|
| Emergency Medicine | 1 | 2006 | 15 | 0.240 |
Why?
|
| Heart Failure | 6 | 2015 | 253 | 0.240 |
Why?
|
| Professional Review Organizations | 1 | 2005 | 1 | 0.240 |
Why?
|
| Homes for the Aged | 1 | 2005 | 7 | 0.230 |
Why?
|
| Drug Utilization | 3 | 2008 | 28 | 0.230 |
Why?
|
| Mass Vaccination | 1 | 2004 | 1 | 0.220 |
Why?
|
| Endarterectomy, Carotid | 3 | 2004 | 11 | 0.220 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2024 | 17 | 0.220 |
Why?
|
| Vaccination Coverage | 1 | 2024 | 14 | 0.220 |
Why?
|
| Peptic Ulcer | 2 | 2001 | 11 | 0.220 |
Why?
|
| Delivery of Health Care | 1 | 2025 | 119 | 0.220 |
Why?
|
| Medical Records | 7 | 2014 | 52 | 0.210 |
Why?
|
| Pandemics | 1 | 2025 | 205 | 0.210 |
Why?
|
| Informed Consent | 1 | 2004 | 26 | 0.200 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 68 | 0.200 |
Why?
|
| Risk Assessment | 8 | 2021 | 631 | 0.190 |
Why?
|
| Age Factors | 6 | 2021 | 740 | 0.190 |
Why?
|
| Prognosis | 4 | 2021 | 812 | 0.190 |
Why?
|
| Research Design | 4 | 2015 | 188 | 0.190 |
Why?
|
| Coronary Disease | 1 | 2003 | 120 | 0.190 |
Why?
|
| Benchmarking | 3 | 2014 | 33 | 0.190 |
Why?
|
| Canada | 1 | 2022 | 60 | 0.180 |
Why?
|
| United Kingdom | 1 | 2022 | 78 | 0.180 |
Why?
|
| Public Health Administration | 1 | 2002 | 15 | 0.180 |
Why?
|
| Health Services for the Aged | 1 | 2002 | 13 | 0.180 |
Why?
|
| Guidelines as Topic | 3 | 2014 | 46 | 0.180 |
Why?
|
| Vascular Surgical Procedures | 3 | 2014 | 55 | 0.180 |
Why?
|
| Interprofessional Relations | 2 | 2019 | 68 | 0.180 |
Why?
|
| Manipulation, Orthopedic | 1 | 2001 | 4 | 0.180 |
Why?
|
| Smoking Cessation | 3 | 2002 | 427 | 0.180 |
Why?
|
| Mammography | 1 | 2002 | 82 | 0.180 |
Why?
|
| Quality Improvement | 2 | 2019 | 127 | 0.160 |
Why?
|
| Logistic Models | 6 | 2014 | 415 | 0.160 |
Why?
|
| Multivariate Analysis | 6 | 2005 | 303 | 0.150 |
Why?
|
| Infectious Disease Medicine | 1 | 2019 | 2 | 0.150 |
Why?
|
| Program Development | 3 | 2010 | 88 | 0.150 |
Why?
|
| Patient Care | 1 | 2019 | 14 | 0.150 |
Why?
|
| Specialization | 1 | 2019 | 19 | 0.150 |
Why?
|
| Attitude of Health Personnel | 2 | 2019 | 154 | 0.150 |
Why?
|
| Insurance Claim Review | 3 | 2013 | 11 | 0.150 |
Why?
|
| Problem-Based Learning | 1 | 2019 | 62 | 0.150 |
Why?
|
| Education, Medical | 1 | 2019 | 68 | 0.150 |
Why?
|
| Thoracic Surgical Procedures | 1 | 1998 | 5 | 0.140 |
Why?
|
| Abdomen | 1 | 1998 | 41 | 0.140 |
Why?
|
| Thromboembolism | 1 | 1998 | 57 | 0.140 |
Why?
|
| Hospitals, Community | 3 | 2004 | 8 | 0.140 |
Why?
|
| International Classification of Diseases | 3 | 2013 | 38 | 0.140 |
Why?
|
| Cholecystectomy | 1 | 1997 | 16 | 0.130 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 1997 | 20 | 0.130 |
Why?
|
| Students | 1 | 2019 | 199 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 46 | 0.130 |
Why?
|
| Program Evaluation | 6 | 2006 | 176 | 0.130 |
Why?
|
| Health Services Research | 6 | 2012 | 45 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 148 | 0.130 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 483 | 0.130 |
Why?
|
| Warfarin | 1 | 1997 | 94 | 0.130 |
Why?
|
| Obesity | 2 | 2013 | 702 | 0.130 |
Why?
|
| Survival Rate | 3 | 2012 | 433 | 0.120 |
Why?
|
| Adult | 11 | 2022 | 8048 | 0.120 |
Why?
|
| African Americans | 4 | 2009 | 353 | 0.120 |
Why?
|
| Drug Therapy, Combination | 2 | 2008 | 210 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2016 | 66 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2002 | 32 | 0.120 |
Why?
|
| Health Personnel | 1 | 2016 | 99 | 0.120 |
Why?
|
| Risk | 2 | 2010 | 138 | 0.120 |
Why?
|
| Venous Thrombosis | 2 | 2010 | 98 | 0.120 |
Why?
|
| Streptococcus pneumoniae | 1 | 2015 | 29 | 0.110 |
Why?
|
| Age Distribution | 4 | 2021 | 75 | 0.110 |
Why?
|
| Blood | 2 | 2005 | 34 | 0.110 |
Why?
|
| Data Collection | 2 | 2012 | 109 | 0.110 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2007 | 173 | 0.100 |
Why?
|
| Atrial Fibrillation | 2 | 1997 | 404 | 0.100 |
Why?
|
| Mandatory Reporting | 1 | 2013 | 5 | 0.100 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2013 | 18 | 0.100 |
Why?
|
| Postoperative Care | 2 | 2017 | 68 | 0.100 |
Why?
|
| Urban Health Services | 1 | 2013 | 9 | 0.100 |
Why?
|
| Hysterectomy | 1 | 2013 | 86 | 0.100 |
Why?
|
| Neoplasms | 1 | 2022 | 879 | 0.100 |
Why?
|
| Rural Health Services | 1 | 2013 | 26 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 1011 | 0.100 |
Why?
|
| Cooperative Behavior | 2 | 2019 | 78 | 0.090 |
Why?
|
| Time and Motion Studies | 1 | 2011 | 7 | 0.090 |
Why?
|
| Feedback | 2 | 2002 | 33 | 0.090 |
Why?
|
| Arthroplasty, Replacement | 2 | 2017 | 4 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2004 | 104 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 29 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2002 | 64 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 149 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 485 | 0.090 |
Why?
|
| Hospitalists | 1 | 2011 | 1 | 0.090 |
Why?
|
| Anesthesia | 1 | 2011 | 26 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2011 | 35 | 0.080 |
Why?
|
| Practice Management | 1 | 2010 | 4 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 53 | 0.080 |
Why?
|
| Health Planning Guidelines | 1 | 2010 | 6 | 0.080 |
Why?
|
| Physician's Role | 1 | 2010 | 29 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2007 | 524 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2001 | 66 | 0.080 |
Why?
|
| Calcium Channel Blockers | 2 | 2001 | 41 | 0.080 |
Why?
|
| Sex Factors | 2 | 2013 | 470 | 0.070 |
Why?
|
| Cephalosporins | 1 | 2008 | 18 | 0.070 |
Why?
|
| Aspirin | 2 | 2001 | 125 | 0.070 |
Why?
|
| Catheters, Indwelling | 1 | 2008 | 19 | 0.070 |
Why?
|
| Sex Distribution | 3 | 2003 | 78 | 0.070 |
Why?
|
| ROC Curve | 2 | 2005 | 144 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2022 | 1283 | 0.070 |
Why?
|
| Survival Analysis | 3 | 2003 | 288 | 0.070 |
Why?
|
| Urinary Tract Infections | 1 | 2008 | 39 | 0.070 |
Why?
|
| Models, Organizational | 2 | 2004 | 18 | 0.070 |
Why?
|
| Economics, Hospital | 1 | 2007 | 1 | 0.060 |
Why?
|
| Societies, Hospital | 1 | 2007 | 1 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 3 | 0.060 |
Why?
|
| Medical Audit | 2 | 2004 | 15 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 466 | 0.060 |
Why?
|
| Home Care Agencies | 1 | 2006 | 1 | 0.060 |
Why?
|
| Probability | 2 | 2005 | 78 | 0.060 |
Why?
|
| Confidence Intervals | 3 | 2008 | 69 | 0.060 |
Why?
|
| Residential Facilities | 1 | 2005 | 4 | 0.060 |
Why?
|
| Infusions, Intravenous | 2 | 2006 | 102 | 0.060 |
Why?
|
| Operating Rooms | 1 | 2005 | 20 | 0.060 |
Why?
|
| Surgery Department, Hospital | 1 | 2005 | 13 | 0.060 |
Why?
|
| Algorithms | 3 | 2013 | 431 | 0.060 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2005 | 3 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2005 | 45 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 225 | 0.050 |
Why?
|
| Helicobacter pylori | 2 | 2001 | 18 | 0.050 |
Why?
|
| Helicobacter Infections | 2 | 2001 | 17 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2005 | 149 | 0.050 |
Why?
|
| Lactams | 1 | 2004 | 3 | 0.050 |
Why?
|
| Methicillin Resistance | 1 | 2004 | 7 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 121 | 0.050 |
Why?
|
| Consent Forms | 1 | 2004 | 1 | 0.050 |
Why?
|
| Acute Disease | 1 | 2004 | 156 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2001 | 79 | 0.050 |
Why?
|
| Prevalence | 2 | 2003 | 521 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 2842 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 3223 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2003 | 464 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2004 | 121 | 0.050 |
Why?
|
| Hospital Bed Capacity, under 100 | 1 | 2003 | 1 | 0.050 |
Why?
|
| Alabama | 1 | 2003 | 4 | 0.050 |
Why?
|
| Blood Transfusion | 2 | 2017 | 77 | 0.050 |
Why?
|
| Bacteremia | 1 | 2003 | 81 | 0.050 |
Why?
|
| Medical Staff, Hospital | 1 | 2002 | 22 | 0.050 |
Why?
|
| Registries | 3 | 2011 | 398 | 0.050 |
Why?
|
| Montana | 1 | 2002 | 5 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2002 | 76 | 0.040 |
Why?
|
| Counseling | 1 | 2001 | 61 | 0.040 |
Why?
|
| Quality of Life | 1 | 2005 | 523 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2002 | 91 | 0.040 |
Why?
|
| Health Education | 1 | 2002 | 76 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2013 | 415 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2001 | 41 | 0.040 |
Why?
|
| Public Policy | 1 | 2000 | 22 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2014 | 237 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 2000 | 54 | 0.040 |
Why?
|
| Seasons | 1 | 2000 | 94 | 0.040 |
Why?
|
| Patient Admission | 1 | 2000 | 30 | 0.040 |
Why?
|
| Health Promotion | 1 | 2002 | 179 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2019 | 63 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 91 | 0.040 |
Why?
|
| Linear Models | 2 | 2012 | 204 | 0.040 |
Why?
|
| Students, Medical | 1 | 2019 | 102 | 0.040 |
Why?
|
| Utilization Review | 1 | 1998 | 10 | 0.030 |
Why?
|
| Cost Control | 1 | 1997 | 9 | 0.030 |
Why?
|
| Smoking | 1 | 2002 | 478 | 0.030 |
Why?
|
| Protective Clothing | 1 | 2017 | 4 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2017 | 3 | 0.030 |
Why?
|
| Myocardial Reperfusion | 1 | 1997 | 5 | 0.030 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2017 | 10 | 0.030 |
Why?
|
| Drainage | 1 | 2017 | 45 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 75 | 0.030 |
Why?
|
| Physician Assistants | 1 | 2016 | 14 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2016 | 55 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 151 | 0.030 |
Why?
|
| Biofilms | 1 | 2017 | 122 | 0.030 |
Why?
|
| Oxygen | 1 | 2017 | 237 | 0.030 |
Why?
|
| Clinical Competence | 1 | 1997 | 245 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 310 | 0.030 |
Why?
|
| Hospital Bed Capacity | 1 | 2015 | 3 | 0.030 |
Why?
|
| Ownership | 1 | 2015 | 6 | 0.030 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2014 | 2 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 105 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 1004 | 0.030 |
Why?
|
| Health Records, Personal | 1 | 2013 | 4 | 0.030 |
Why?
|
| Rectum | 1 | 2013 | 50 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2013 | 51 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2013 | 30 | 0.020 |
Why?
|
| Risk Adjustment | 1 | 2012 | 8 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 123 | 0.020 |
Why?
|
| Comoros | 1 | 2012 | 1 | 0.020 |
Why?
|
| Colectomy | 1 | 2012 | 5 | 0.020 |
Why?
|
| Osteoarthritis, Hip | 1 | 2012 | 12 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2012 | 17 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 261 | 0.020 |
Why?
|
| Osteoarthritis, Knee | 1 | 2012 | 26 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2012 | 54 | 0.020 |
Why?
|
| Insurance Claim Reporting | 1 | 2011 | 3 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2011 | 211 | 0.020 |
Why?
|
| Morbidity | 1 | 2010 | 60 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 788 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2009 | 11 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 739 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2008 | 8 | 0.020 |
Why?
|
| Curriculum | 1 | 2011 | 307 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2008 | 68 | 0.020 |
Why?
|
| Patient Selection | 1 | 2008 | 151 | 0.020 |
Why?
|
| Health Services | 1 | 2006 | 12 | 0.020 |
Why?
|
| Physicians, Family | 1 | 2006 | 14 | 0.020 |
Why?
|
| Observation | 1 | 2006 | 5 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2005 | 16 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 191 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2006 | 81 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 1032 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 82 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2005 | 25 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2005 | 19 | 0.010 |
Why?
|
| Microbiological Techniques | 1 | 2005 | 8 | 0.010 |
Why?
|
| Penicillins | 1 | 2005 | 12 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2005 | 46 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2006 | 169 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 25 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2004 | 31 | 0.010 |
Why?
|
| Random Allocation | 1 | 2004 | 152 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2002 | 226 | 0.010 |
Why?
|
| Physician Executives | 1 | 2001 | 5 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2001 | 21 | 0.010 |
Why?
|
| Surgical Mesh | 1 | 2001 | 14 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 2000 | 10 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2001 | 191 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 44 | 0.010 |
Why?
|